| 1 |
29523599 | MRP2 Inhibition by HIV Protease Inhibitors in Rat and Human Hepatocytes: A Quantitative Confocal Microscopy Study. | 2018 May |
1 |
| 2 |
27142945 | Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans. | 2016 May |
1 |
| 3 |
27543355 | Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug. | 2016 Oct 15 |
3 |
| 4 |
22027652 | Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular disposition. | 2011 Dec |
4 |
| 5 |
19842932 | Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients. | 2009 Oct |
2 |
| 6 |
18455890 | Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor. | 2008 Jul 9 |
2 |
| 7 |
17890284 | Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes. | 2007 Nov |
1 |